Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density

Published:2021-12-16 Issue:2 Volume:37 Page:256-264
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Poole Kenneth ES¹^ORCID,Treece Graham M²,Pearson Rose A²,Gee Andrew H²,Bolognese Michael A³^ORCID,Brown Jacques P⁴,Goemaere Stefan⁵,Grauer Andreas⁶,Hanley David A⁷,Mautalen Carlos⁸,Recknor Chris⁹,Yang Yu‐Ching⁶,Rojeski Maria⁶,Libanati Cesar¹⁰^ORCID,Whitmarsh Tristan¹¹^ORCID

Affiliation:

1. Department of Medicine University of Cambridge and Addenbrooke's Hospital Cambridge UK

2. Department of Engineering University of Cambridge Cambridge UK

3. Bethesda Health Research Center Bethesda MD USA

4. CHU de Québec Research Centre and Laval University Quebec City Canada

5. Ghent University Hospital Ghent Belgium

6. Amgen Inc. Thousand Oaks CA USA

7. University of Calgary Calgary Canada

8. Centro de Osteopatias Medicas Buenos Aires Argentina

9. United Osteoporosis Centers Gainesville GA USA

10. UCB Pharma Brussels Belgium

11. Institute of Astronomy, University of Cambridge Cambridge UK

Funder

Amgen

NIHR Cambridge Biomedical Research Centre

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4465

Reference38 articles.

1. Skeletal actions of intermittent parathyroid hormone: Effects on bone remodelling and structure

2. Romosozumab in Postmenopausal Women with Low Bone Mineral Density

3. Sclerostin expression by osteocytes is a delayed event; implications for the control of bone formation;Poole KES;J Bone Miner Res.,2005

4. Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys

5. Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing osteoporosis diagnosis and fracture prediction: role of quantitative CT and future research directions;Archives of Orthopaedic and Trauma Surgery;2024-08-24

2. The potential effect of romosozumab on perioperative management for instrumentation surgery;JOR SPINE;2024-08-05

3. Drug utilization pattern of romosozumab and other osteoporosis treatments in Japan, 2019–2021;Journal of Bone and Mineral Metabolism;2024-07-10

4. Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty;Archives of Osteoporosis;2024-03-21

5. 3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate;Journal of Bone and Mineral Research;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3